I work as a US equity and macro analyst at Chinese Investors in Shanghai, and have opened my own private hedge fund in London, focusing on US equity investments. My primary research focus is US-listed Chinese equities.
Habitually 1-2 years ahead on equity picks bull runs - learning patience. Looking for attractively valued small caps and above-average Betas. Tend to lean towards Alternative Energy, Health & Wellness, Vice Plays and Trend Tech.